Liu et al., 2015 - Google Patents
Effect of surface hydrophobicity on the function of the immobilized biomineralization protein Mms6Liu et al., 2015
View PDF- Document ID
- 364250984153150081
- Author
- Liu X
- Zhang H
- Nayak S
- Parada G
- Anderegg J
- Feng S
- Nilsen-Hamilton M
- Akinc M
- Mallapragada S
- Publication year
- Publication venue
- Industrial & Engineering Chemistry Research
External Links
Snippet
Magnetotactic bacteria produce magnetic nanocrystals with uniform shapes and sizes in nature, which has inspired in vitro synthesis of uniformly sized magnetite nanocrystals under mild conditions. Mms6, a biomineralization protein from magnetotactic bacteria with a …
- 102000004169 proteins and genes 0 title abstract description 176
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANO-TECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
- B82Y30/00—Nano-technology for materials or surface science, e.g. nano-composites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Biehl et al. | Synthesis, characterization, and applications of magnetic nanoparticles featuring polyzwitterionic coatings | |
| Galloway et al. | Protein and peptide biotemplated metal and metal oxide nanoparticles and their patterning onto surfaces | |
| Kashyap et al. | Nucleation of iron oxide nanoparticles mediated by Mms6 protein in situ | |
| Wu et al. | Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications | |
| Daou et al. | Coupling agent effect on magnetic properties of functionalized magnetite-based nanoparticles | |
| Liu et al. | Design of covalently functionalized carbon nanotubes filled with metal oxide nanoparticles for imaging, therapy, and magnetic manipulation | |
| Frimpong et al. | Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications | |
| Alphandéry et al. | Assemblies of aligned magnetotactic bacteria and extracted magnetosomes: what is the main factor responsible for the magnetic anisotropy? | |
| Garcia Rubia et al. | pH-dependent adsorption release of doxorubicin on MamC-biomimetic magnetite nanoparticles | |
| Wang et al. | Simple ligand exchange reactions enabling excellent dispersibility and stability of magnetic nanoparticles in polar organic, aromatic, and protic solvents | |
| Shukoor et al. | Fabrication of a silica coating on magnetic γ-Fe2O3 nanoparticles by an immobilized enzyme | |
| Chan et al. | Magnetically guided theranostics: optimizing magnetic resonance imaging with sandwich-like kaolinite-based iron/platinum nanoparticles for magnetic fluid hyperthermia and chemotherapy | |
| Castellanos-Rubio et al. | Highly reproducible hyperthermia response in water, agar, and cellular environment by discretely PEGylated magnetite nanoparticles | |
| Liu et al. | Kinetics and mechanisms of protein adsorption and conformational change on hematite particles | |
| Bird et al. | Taking a hard line with biotemplating: cobalt-doped magnetite magnetic nanoparticle arrays | |
| Zhang et al. | Morphological transformations in the magnetite biomineralizing protein Mms6 in iron solutions: a small-angle X-ray scattering study | |
| Mirabello et al. | Understanding the formation mechanism of magnetic mesocrystals with (cryo-) electron microscopy | |
| Alsharif et al. | Biofunctionalizing magnetic nanowires toward targeting and killing leukemia cancer cells | |
| Liu et al. | Effect of surface hydrophobicity on the function of the immobilized biomineralization protein Mms6 | |
| Pohl et al. | Decoding biomineralization: interaction of a Mad10-derived peptide with magnetite thin films | |
| Thomas et al. | Handbook of magnetic hybrid nanoalloys and their nanocomposites | |
| Solodov et al. | Understanding the nucleation and growth of iron oxide nanoparticle formation by a “heating-up” process: An NMR relaxation study | |
| Guillen et al. | pH-Responsive Metal–Organic Framework Thin Film for Drug Delivery | |
| Lee et al. | Peptidoglycan-binding protein metamaterials mediated enhanced and selective capturing of Gram-positive bacteria and their specific, ultra-sensitive, and reproducible detection via surface-enhanced Raman scattering | |
| Phakatkar et al. | In situ microscopic studies on the interaction of multi-principal element nanoparticles and bacteria |